<DOC>
	<DOCNO>NCT00689273</DOCNO>
	<brief_summary>To evaluate efficacy , safety , tolerability , pharmacodynamics , pharmacokinetics patient osteoarthritic pain knee . The painful knee joint identify index joint screening , joint use pain assessment throughout study .</brief_summary>
	<brief_title>Randomized , Double-Blind , Placebo-Controlled , Phase 2 Study In Subjects With Osteoarthritic Pain Of The Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Male female race , age 18 75 year inclusive Female subject must nonchildbearing potential negative pregnancy test Screening . Osteoarthritis knee least 6 month duration meet American College Rheumatology Criteria . For radiographic criterion Xray must take within last 5 year . If none available , one take diagnostic criterion confirm prior randomization . Willing able discontinue current analgesic therapy , include OTC pain medication topical analgesic OA pain , period begin washout phase ( last 2 day 5 halflives patient 's current analgesic medication prior Day 6 ) continue entire duration study . As exception , acetaminophen may use nonjoint relate pain dos ≤1 g/day discretion qualify member study team . If subject evidence history clinically significant endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , renal , psychiatric , neurological disease , investigator must confirm disease stable ( least 4 week ) control . QTc interval ≤450 msec PR interval ≤210 msec Screening ECG . Pregnant lactate female , female childbearing potential . Arthroscopy perform index knee within 1 year screening . Active depression define meet The Hospital Anxiety Depression Scale ( HADS ) &gt; 10 . Unwillingness refrain consumption grapefruit grapefruit juice 7 day prior first dose study medication completion study . First degree high AV block , define PR interval &gt; 210 msec , bundle branch block , fascicular block intraventricular conduction delay clinically relevant abnormality screen ECG . Active malignancy type history malignancy within 10 year ( exception subject history treat basal cell carcinoma ) . Symptomatic OA hip ipsilateral index knee patient considers painful knee . Use prohibit medication list , absence appropriate washout period . The following analgesic agent must discontinue within 48 hour 5 half life analgesic wash prior baseline period ( Day 6 Day 0 ) ; NSAIDs selective COX2 inhibitor ; Acetaminophen ( exception acetaminophen may use nonjoint relate pain dos ≤1g/day ) ; Opioids . Oral I/M corticosteroid within 4 week prior screen . I/A steroid within 12 week prior baseline study joint joint within 4 week prior baseline , I/A hyaluronic acid within 24 week prior baseline ; Use concomitant medication CYP3A inhibitor CYP3A inducer , Pglycoprotein substrates within 48 hour 5 half life prior baseline .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>PF-04136309 CCR2 osteoarthritic pain knee , phase 2 placebo multicenter double-blind placebo-controlled</keyword>
</DOC>